|
|||||
|
|
Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method |
|
| Authors: | A. Hillarp K. D. Friedman D. Adcock‐Funk S. Tiefenbacher W. L. Nichols D. Chen M. Stadler B. A. Schwartz |
| Affiliation: | 1. Malm? Centre for Thrombosis and Haemostasis, Department of Clinical Chemistry, Malm? University Hospital, Malm?, Sweden;2. Medical Sciences Institute, Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, WI, USA;3. Colorado Coagulation, Laboratory Corporation of America? Holdings, Englewood, CO, USA;4. Special Coagulation Laboratory, Mayo Clinic, Rochester, MN, USA;5. Octapharma OPG, Vienna, Austria;6. Octapharma USA, Hoboken, NJ, USA |
| Abstract: | |
| Keywords: | RCo assays ristocetin von Willebrand disease von Willebrand factor |